Yahoo Finance StockCall Early Morning Insight into WCRX, DVAX, ISIS, ACT, and AVNR
StockCall.com Provides Stock Research on Warner Chilcott plc, Dynavax Technologies Corp., Isis Pharmaceuticals Inc., Actavis Inc., and Avanir Pharmaceuticals.
New York City, New York -- (May 15, 2013)
One of the major trends to emerge in the healthcare sector in the past year has been the expiration of patents on several blockbuster drugs. The “patent cliff” is likely to have a significant impact on top-line of major drug manufacturers as it will lead to increasing competition from generic drug makers such as Actavis Inc. (NYSE:ACT - News) and Avanir Pharmaceuticals Inc. (NASDAQ:AVNR - News). For drug manufacturers such as Warner Chilcott Plc (NASDAQ:WCRX - News), Dynavax Technologies Corporation (NASDAQ:DVAX - News), and ISIS Pharmaceuticals Inc. (NASDAQ:ISIS - News), the key will be to boost their product pipeline. Another major development in the healthcare sector is the Affordable Care Act (ACA) which was upheld by the Supreme Court last year. This sector ended sharply higher on Tuesday, tracking gains in the broad market as it rallied to finish at record high levels. StockCall has issued technical analysis and charting reports on WCRX, DVAX, ISIS, ACT, and AVNR. Download these free reports now at
www.stockcall.com/todaysopinions
Shares of Warner Chilcott Plc edged higher on Tuesday; however, the gains were limited. The stock closed 0.05% higher at $18.92 on above average volume of 13.37 million. Warner Chilcott’s shares have had an excellent run in the last three sessions, gaining more than 26%. Year-to-date, the stock has now gained more than 57.10%, easily outperforming the broad market. Its MACD chart suggests that market sentiment is currently bullish. Download the free research on WCRX today by registering at
www.StockCall.com/WCRX051513.pdf
Shares of Dynavax Technologies Corporation rallied in yesterday’s trading session, extending their gains from previous sessions. The stock closed 5.58% higher at $2.46 on above average volume of 2.05 million, taking its gains in the last three sessions to over 11.80%. The company’s shares have seen a series of highs over the past week which is a bullish signal. The stock has also crossed its 50-day moving average recently, which further confirms the upbeat trend. Sign up and have access to our free report on DVAX at
www.StockCall.com/DVAX051513.pdf
Another major gainer in the healthcare sector on Tuesday was ISIS Pharmaceuticals Inc. The stock rose to an intraday high of $20.27 before finishing the day 4.38% higher at $20.24 on volume of 1.64 million, taking its gains in the last three sessions to nearly 9.50%. ISIS shares have bounced back in the last three trading sessions after falling sharply last week. The stock’s MACD chart, however, is still giving bearish signals. Sign up and read the complimentary report on ISIS at
www.StockCall.com/ISIS051513.pdf
Actavis Inc.’s shares edged higher in trading yesterday, touching a 52-week high of $126.33. The stock closed 0.96% higher at $121.68 on above average volume of 3.72 million. Shares of ACT have now gained nearly 14% in the last three trading sessions. Year-to-date, the stock has gained nearly 41.50%, easily outperforming the S&P 500. The company’s shares are trading well above their 50-day and 200-day moving averages which is a bullish signal. The free report on ACT can be downloaded by signing up now at
www.StockCall.com/ACT051513.pdf
Shares of Avanir Pharmaceuticals Inc. edged higher in yesterday’s trading session. The stock traded between $3.29 and $3.40 before finishing the day 2.72% higher at $3.40 on volume of 1.26 million. Avanir’s shares have now gained nearly 7% in the last three sessions. Shares of AVNR have seen a series of highs over the past week which is a bullish signal. The stock’s 50-day moving average recently crossed above the 200-day moving average, forming a “golden cross”. This is another strong positive signal. Free report on AVNR can be accessed by registering at
www.StockCall.com/AVNR051513.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
Contact Person:
William T. Knight
Email: info@stockcall.com
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)
